DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Fizazi K, Scher HI, Miller K. , et al.
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial.
Lancet Oncol 2014;
15 (10) 1147-1156
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.